Publicaciones en las que colabora con José Gil Martínez (21)

2020

  1. Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy

    Clinical and Translational Oncology, Vol. 22, Núm. 6, pp. 852-859

2017

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1388-1392

2016

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in elderly patients. A systematic literature review

    Surgical Oncology, Vol. 25, Núm. 4, pp. 378-384

  2. Effectiveness and failures of a fast track protocol after cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy in patients with peritoneal surface malignancies

    Surgical Oncology, Vol. 25, Núm. 4, pp. 349-354

  3. Hyperthermic intraperitoneal chemotherapy with paclitaxel or cisplatin in patients with stage III-C/IV ovarian cancer. is there any difference?

    Surgical Oncology, Vol. 25, Núm. 3, pp. 164-170

  4. Use of 18F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue

    European Journal of Radiology, Vol. 85, Núm. 10, pp. 1824-1828

2015

  1. HIPEC in ovarian cancer: Treatment of a new era or is it the end of the pipeline?

    Gynecologic Oncology, Vol. 139, Núm. 2, pp. 363-368

  2. The Role of Hyperthermic Intraperitoneal Chemotherapy Using Paclitaxel in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer Patients with Microscopic Residual Disease after Cytoreduction

    Annals of Surgical Oncology, Vol. 22, Núm. 3, pp. 987-993

2014

  1. Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 179, pp. 88-93

  2. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer

    European Journal of Surgical Oncology, Vol. 40, Núm. 8, pp. 970-975

  3. Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer

    Annals of Surgical Oncology, Vol. 21, Núm. 7, pp. 2383-2389

2012

  1. Cirugí del tracto urinario en pacientes con carcinomatosis peritoneal ová rica tratadas con citorreducción y quimioterapia intraperitoneal intraoperatoria hipertérmica

    Cirugia Espanola, Vol. 90, Núm. 3, pp. 162-168

  2. Enfermedad de Castleman unicéntrica pélvica

    Cirugia Espanola

2011

  1. Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma

    European Journal of Obstetrics and Gynecology and Reproductive Biology

  2. Letter to the editor: Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer. Some considerations

    British Journal of Radiology

  3. Perforation and expulsion through the anus of catheter after gastric banding

    American Surgeon, Vol. 77, Núm. 9, pp. 1264-1265

  4. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer

    European Journal of Surgical Oncology, Vol. 37, Núm. 6, pp. 543-548

2010

  1. Screening for the effectiveness of conservative treatment in chronic anal fissure patients using anorectal manometry

    International Journal of Colorectal Disease, Vol. 25, Núm. 5, pp. 649-654

2009

  1. Gastrojejunal anastomotic stenosis in laparoscopic gastric bypass with a circular stapler (21 mm): Incidence, treatment and long-term follow-up

    Obesity Surgery, Vol. 19, Núm. 12, pp. 1631-1635

2007

  1. Influence of the neo-adjuvant radiochemotherapy as a factor in the surgical treatment of rectal cancer by expert surgeon. A comparative study

    International Journal of Colorectal Disease, Vol. 22, Núm. 10, pp. 1233-1238